Cargando…
Therapeutic Options for Visceral Leishmaniasis
Visceral leishmaniasis (VL), also known as Kala-Azar, is a disseminated protozoal infection caused principally by Leishmania donovani and Leishmania infantum (known as Leishmania chagasi in South America). The therapeutic options for VL are diverse and depend on different factors, such as the geogra...
Autores principales: | Monge-Maillo, Begoña, López-Vélez, Rogelio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837193/ https://www.ncbi.nlm.nih.gov/pubmed/24170666 http://dx.doi.org/10.1007/s40265-013-0133-0 |
Ejemplares similares
-
Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region
por: Monge-Maillo, Begoña, et al.
Publicado: (2014) -
Topical Paromomycin and Gentamicin for New World Cutaneous Leishmaniasis in Panama
por: Monge-Maillo, Begoña, et al.
Publicado: (2014) -
Migration and Malaria in Europe
por: Monge-Maillo, Begoña, et al.
Publicado: (2012) -
Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009) -
Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014)